Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Label with surface ornamentation
Music composition automation including song structure
Cosmetic product including vegetable oil blend
Electronic device with multi-orientation
Plants and seeds of hybrid corn variety CH717591
Registration and network access control
Method and system for expanding axial coverage in iterative reconstruction in computer tomography (CT)
  Randomly Featured Patents
Electronic parts mounting apparatus
Method of detachably securing an explosive charge container in a hollow carrier for a perforating device
Dynamic threshold voltage 6T SRAM cell
Hardware semaphores for a multi-processor system within a shared memory architecture
Microencapsulated compositions for endoluminal tissue engineering
Two part vehicle transmission shipping container
Heat exchanger plates and manufacturing method
Sensor chip for biochemical analysis
Piezoelectric vibrator, piezoelectric vibrator device having the same and circuit device having the piezoelectric vibrator device
Semiconductor package board using a metal base